The reduction by Ed Yardeni, president and chief investment strategist of Yardeni Research, is notable for a few reasons, one ...

Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.

Goldman looked at periods of S&P 500 ( SP500) corrections above 10% since 1990. Its broad observation was that, in absolute ...

Goldman Sachs is waving a red flag for global equities as the S&P 500 edges closer to a full-blown correction, now down more ...

Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of The Goldman Sachs Group, Inc. (NYSE:GS). In a ...

Representative Josh Gottheimer (D-New Jersey) recently sold shares of The Goldman Sachs Group, Inc. (NYSE:GS). In a filing disclosed on March 06th, the Representative disclosed that they had sold ...

The deal size was increased to $125M in common stock from $100M in common stock. Goldman Sachs, BofA, Barclays and Oppenheimer acted as joint ...

What next for the SCHD ETF now that analysts at Citigroup, Goldman Sachs, and HSBC have slashed their S&P 500 forecast?

The Irvine-based biopharmaceutical company today announced the underwritten public offering after market close today.

Tarsus Pharmaceuticals (TARS) announced the commencement of an underwritten public offering of $100M of shares of its common stock. All shares ...